Trephine
AboutSpecialtiesPricingLoading...

Copyright © 2024 Trephine. All rights reserved. The content of this site is intended for health care professionals.

TREPHINE

Terms Of UsePrivacy Policy

European heart journalJournal Article

16 Jan 2025

Xylitol exposure and cardiovascular risk.

No abstract available

References:

  • Witkowski  M, Nemet  I, Li  XS, Wilcox  J, Ferrell  M, Alamri  H, et al.  Xylitol is prothrombotic and associated with cardiovascular risk. Eur Heart J  2024;45:2439–52. 10.1093/eurheartj/ehae244
  • Takayasu  S, Kamba  A, Yoshida  K, Terui  K, Watanuki  Y, Ishigame  N, et al.  Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report. BMC Nephrol  2020;21:157. 10.1186/s12882-020-01814-9
  • Li  J, Yu  G, Fan  J. Alditols and monosaccharides from sorghum vinegar can attenuate platelet aggregation by inhibiting cyclooxygenase-1 and thromboxane-A2 synthase. J Ethnopharmacol  2014;155:285–92. 10.1016/j.jep.2014.05.018
  • Bordier  V, Teysseire  F, Drewe  J, Madörin  P, Bieri  O, Schmidt-Trucksäss  A, et al.  Effects of a 5-week intake of erythritol and xylitol on vascular function, abdominal fat and glucose tolerance in humans with obesity: a pilot trial. BMJ Nutr Prev Health  2023;6:264–72. 10.1136/bmjnph-2023-000764
  • Beer  JH, Allemann  M. Xylitol: bitter cardiovascular data for a successful sweetener. Eur Heart J  2024;45:2453–5. 10.1093/eurheartj/ehae252

Article info

Journal issue:

  • Volume: 46
  • Issue: 3

Doi:

10.1093/eurheartj/ehae730

More resources:

Ovid Technologies, Inc.

Full Text Sources

Paid

PubMed Central

Full Text Sources

Free resource

Silverchair Information Systems

Full Text Sources

Paid

Share: